Identity
- Method
- LC-MS
- Status
- Pass
Historical batch record
This report covers a past batch. The product page shows current availability.
Certificate of Analysis
NAD+ 500 mg
- Batch ND50026205JS
- Tested July 31, 2026
- Freedom Diagnostics Testing
Measured values
- Purity
- 99.87% Pass Purity measured by the laboratory.
- Measured content
- 454.82 mg ReportedContent measured during testing.
- Labeled content
- 500 mg Amount stated on the vial submitted for testing.
Testing overview
- IdentityPass
- PurityPass
- Measured contentMeasured
- SterilityPass
- Fentanyl screeningPass
Independent laboratory data
| Test | Laboratory evidence | Status |
|---|---|---|
| Identity |
| Pass |
| Purity |
| Pass |
| Measured content |
| Reported |
| Sterility |
| Pass |
| Fentanyl Screen |
| Pass |
Purity
- Method
- HPLC-UV
- Result
- 99.87%
- Status
- Pass
Measured content
- Result
- 454.82 mg
- Status
- Reported
Sterility
- Result
- No Detectable Microbial DNA
- Status
- Pass
Fentanyl Screen
- Method
- Immunoassay
- Specification
- Immunoassay, 50 ng/mL cutoff
- Result
- Not detected
- Status
- Pass
Original document
Certificate pages
Expand to view pages
Original document
Certificate pages
Source documentation
Laboratory Report
Original analysis from the independent laboratory.
Report details
- Laboratory
- Freedom Diagnostics Testing
- COA reference
- PepS2607280579
- Analysis date
- July 31, 2026
- Certificate version
- 1
Freedom Diagnostics TestingIndependent Testing Laboratorycoas.freedomdiagnosticstesting.com
